A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2004
11/25/2004	US20040235803 Dispersible formulation of an anti-inflammatory agent
11/25/2004	US20040235790 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
11/25/2004	US20040235763 Expression vector involved in proliferation or replication, or immune protection of HSV; or transcriptional and/or translational products of target sequence
11/25/2004	US20040235758 Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery
11/25/2004	US20040235751 Reduction of zinc-induced neurotoxic injury by blockade of nitric oxide synthesis
11/25/2004	US20040235747 Administering Activity Dependent Neurotrophic Factor (ADNF) polypeptide as neuroprotective agent; multiple sclerosis
11/25/2004	US20040235716 Novel cyclosporins
11/25/2004	US20040235115 Comprises serine protease for use in treating and preventing heart attack, stroke, gangrene, deep venous thrombosis and peripheral arterial occlusion; fibrinolytic therapy
11/25/2004	US20040235082 Fat regulation
11/25/2004	US20040235079 Identifying modulators associated with heme independent inhibition of soluble guanylyl cyclase for use in treatment of infection, hypertension and cardiovascular disorders
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040234674 Artichoke leaf extracts
11/25/2004	US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/25/2004	US20040234628 Topical composition for the treatment of skin disorders and methods of using the same
11/25/2004	US20040234589 Mixture with carrier; storage stability packaging; freeze drying
11/25/2004	US20040234543 Hepatitis virus
11/25/2004	US20040234450 Compositions, methods, apparatuses, and systems for singlet oxygen delivery
11/25/2004	US20040232410 Light emitting diode, support & method of manufacture
11/25/2004	CA2525367A1 Use of citrate lyase inhibitors and tricarboxylate transporter inhibitors in the treatment of cancer
11/25/2004	CA2525107A1 Novel fibroblast growth factors and methods of use thereof
11/25/2004	CA2525099A1 Cytotoxic indeno and isoindoloisoquinolones
11/25/2004	CA2524827A1 Controlled release formulation of erythromycin derivatives
11/25/2004	CA2524436A1 Benzimidazoles, compositions containing such compounds and methods of use
11/25/2004	CA2523943A1 Compositions and methods for wt1 specific immunotherapy
11/25/2004	CA2523001A1 Therapeutic use of anti-cs1 antibodies
11/25/2004	CA2523000A1 Oral care methods and products
11/25/2004	CA2522690A1 Inhibition of drug binding to serum albumin
11/25/2004	CA2522614A1 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
11/24/2004	EP1479379A1 Dry liposomal PVP-iodine compositions
11/24/2004	EP1478401A2 Compositions comprising dietary fat complexer and methods for their use
11/24/2004	EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
11/24/2004	EP1420799A4 Use of atazanavir in hiv therapy
11/24/2004	EP1317243B1 Hair dyeing agents containing indigo derivatives
11/24/2004	EP1011664B1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
11/24/2004	CN1549813A Pyrimidineamines as angiogenesis modulators
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1548167A Hemostatic antibiotic products and preparnig method thereof
11/24/2004	CN1176645C Pigment compositions for dyeing hair
11/18/2004	WO2004100525A2 System and method for blocking television signal having multiple different content ratings
11/18/2004	WO2004099156A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004098647A2 Claudins’ underexpression as markers of tumor metastasis
11/18/2004	WO2004098539A2 Kinases and phosphatases
11/18/2004	WO2004098538A2 Nitrosated and nitrosylated compounds, compositions and methods of use
11/18/2004	WO2004098536A2 Anti-viral activity of cathelicidin peptides
11/18/2004	WO2004098535A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/18/2004	WO2004098534A2 Methods for delivering angiogenic modulators using pox viruses
11/18/2004	WO2004098533A2 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/18/2004	WO2004098532A2 Methods of reducing an immune response
11/18/2004	WO2004098531A2 Increased transduction using abc transporter substrates and/or inhibitors
11/18/2004	WO2004098530A2 Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
11/18/2004	WO2004098529A2 Therapeutic compositions and vaccines by glycosyl-phosphatidylinositol (gpi)-anchored cytokines and immunostimulatory molecules
11/18/2004	WO2004098528A2 Pyrazole-amine compounds useful as kinase inhibitors
11/18/2004	WO2004098526A2 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
11/18/2004	WO2004098524A2 Lipid platinum complexes and methods of use thereof
11/18/2004	WO2004098523A2 Intraocular brachytherapy device and method
11/18/2004	WO2004098522A2 Gemini vitamin d3 compounds and methods of use thereof
11/18/2004	WO2004098521A2 Treatment and diagnostics of cancer
11/18/2004	WO2004098520A2 Compounds and compositions as protein kinase inhibitors
11/18/2004	WO2004098519A2 Ginkgo biloba extract as a treatment for therapeutic induced neurotoxicity
11/18/2004	WO2004098518A2 Pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004098516A2 Cyclic derivatives as modulators of chemokine receptor activity
11/18/2004	WO2004098515A2 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
11/18/2004	WO2004098514A2 Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
11/18/2004	WO2004098513A2 Nasal administration of the lh-rh analog leuprolide
11/18/2004	WO2004098512A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
11/18/2004	WO2004098511A2 Methods and devices for creating electrical block at specific targeted sites in cardia tissue
11/18/2004	WO2004098510A2 Cystic fibrosis therapy
11/18/2004	WO2004098509A2 Compositions for inducing immune responses
11/18/2004	WO2004098508A2 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cells
11/18/2004	WO2004098507A2 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof
11/18/2004	WO2004098506A2 Treatment for age-related macular degeneration
11/18/2004	WO2004098505A2 Attenuation of ischemia/reperfusion injury
11/18/2004	WO2004098504A2 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines and methods of treating tumors
11/18/2004	WO2004098503A2 Drug releasing biodegradable fiber for delivery of therapeutics
11/18/2004	WO2004098502A2 Cngh0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses.
11/18/2004	WO2004098501A2 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
11/18/2004	WO2004098500A2 CARBACEPHEM ss-LACTAM ANTIBIOTICS
11/18/2004	WO2004098498A2 Indole acetic acid derivatives and their use as pharmaceutical agents
11/18/2004	WO2004098497A2 Cd4+ human papillomavirus (hpv) epitopes
11/18/2004	WO2004098496A2 Compounds for the treatment of metabolic disorders
11/18/2004	WO2004098494A2 Compounds, compositions, and methods
11/18/2004	WO2004098492A2 Trans-golgi network-associated processes, methods and compositions related thereto
11/18/2004	WO2004098491A2 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES
11/18/2004	WO2004098490A2 Mesoderm and definitive endoderm cell populations
11/18/2004	WO2004098489A2 Compositions and methods for modulation of specific epitopes of hsp60
11/18/2004	WO2004098487A2 Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 5 (tmprss5)
11/18/2004	WO2004087052A3 Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
11/18/2004	WO2004082628A3 Improved bioavailability and improved delivery of acidic pharmaceutical drugs
11/18/2004	WO2004082625A3 Self-emulsifying compositions, methods of use and preparation
11/18/2004	WO2004082605A3 Bicyclic anilide spirohydantoin cgrp receptor antagonists
11/18/2004	WO2004078127A3 Continuous delivery methods for treating hepatitis virus infection
11/18/2004	WO2004073627A3 Novel therapeutic method and compositions for topical administration
11/18/2004	WO2004073613A3 A medicine and food
11/18/2004	WO2004069193A9 Methods and compositions for inhibiting cholesterol uptake
11/18/2004	WO2004069157A3 Combinational use of long-acting and short-acting anti-histamines for ocular allergies
11/18/2004	WO2004054515A3 Thrombopoietin mimetics
11/18/2004	WO2004043353A3 Compositions and methods for treating acute myeloid leukemia
11/18/2004	WO2004043350A3 PURIFIED COMPOUNDS THAT INHIBIT INTRACELLULAR α4/PAXILLIN BINDING
11/18/2004	WO2004037997A3 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof

1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 295